Subacute Partially Reversible Leukoencephalopathy Expands the Aicardi-Goutieres Syndrome Phenotype

Carregando...
Imagem de Miniatura
Citações na Scopus
1
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
MDPI
Citação
BRAIN SCIENCES, v.13, n.8, article ID 1169, 12p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Objective: To report a series of atypical presentations of Aicardi-Goutieres syndrome. Methods: Clinical, neuroimaging, and genetic data. Results: We report a series of six unrelated patients (five males) with a subacute loss of developmental milestones, pyramidal signs, and regression of communication abilities, with onset at ages ranging from 7 to 20 months, reaching a nadir after 4 to 24 weeks. A remarkable improvement of lost abilities occurred in the follow-up, and they remained with residual spasticity and dysarthria but preserved cognitive function. Immunization or febrile illness occurred before disease onset in all patients. CSF was normal in two patients, and in four, borderline or mild lymphocytosis was present. A brain CT scan disclosed a subtle basal ganglia calcification in one of six patients. Brain MRI showed asymmetric signal abnormalities of white matter with centrum semi-ovale involvement in five patients and a diffuse white matter abnormality with contrast enhancement in one. Four patients were diagnosed and treated for acute demyelinating encephalomyelitis (ADEM). Brain imaging was markedly improved with one year or more of follow-up (average of 7 years), but patients remained with residual spasticity and dysarthria without cognitive impairment. Demyelination relapse occurred in a single patient four years after the first event. Whole-exome sequencing (WES) was performed in all patients: four of them disclosed biallelic pathogenic variants in RNASEH2B (three homozygous p.Ala177Thr and one compound heterozygous p.Ala177Thr/p.Gln58*) and in two of them the same homozygous deleterious variants in RNASEH2A (p.Ala249Val). Conclusions: This report expands the phenotype of AGS to include subacute developmental regression with partial clinical and neuroimaging improvement. Those clinical features might be misdiagnosed as ADEM.
Palavras-chave
reversible leukoencephalopathy, Aicardi-Goutieres syndrome, acute demyelinating encephalomyelitis
Referências
  1. AICARDI J, 1984, ANN NEUROL, V15, P49, DOI 10.1002/ana.410150109
  2. Crow YJ, 2008, DEV MED CHILD NEUROL, V50, P410, DOI 10.1111/j.1469-8749.2008.02062.x
  3. Crow YJ, 2006, NAT GENET, V38, P910, DOI 10.1038/ng1842
  4. Crow YJ, 2006, NAT GENET, V38, P917, DOI 10.1038/ng1845
  5. Crow YJ, 2015, NAT REV IMMUNOL, V15, P429, DOI 10.1038/nri3850
  6. Crow YJ, 2015, AM J MED GENET A, V167, P296, DOI 10.1002/ajmg.a.36887
  7. D'Arrigo S, 2008, DEV MED CHILD NEUROL, V50, P631, DOI 10.1111/j.1469-8749.2008.03033.x
  8. Gnom A.D., US
  9. Kothare SV, 2006, CHILD NERV SYST, V22, P1503, DOI 10.1007/s00381-006-0112-9
  10. La Piana R, 2016, NEUROLOGY, V86, P28, DOI 10.1212/WNL.0000000000002228
  11. La Piana R, 2014, NEUROPEDIATRICS, V45, P406, DOI 10.1055/s-0034-1393710
  12. La Piana R, 2014, AM J MED GENET A, V164, P815, DOI 10.1002/ajmg.a.36360
  13. LEBON P, 1988, J NEUROL SCI, V84, P201, DOI 10.1016/0022-510X(88)90125-6
  14. Livingston JH, 2016, NEUROPEDIATRICS, V47, P355, DOI 10.1055/s-0036-1592307
  15. Livingston JH, 2014, J MED GENET, V51, P76, DOI 10.1136/jmedgenet-2013-102038
  16. McEntagart M, 1998, NEUROPEDIATRICS, V29, P163, DOI 10.1055/s-2007-973555
  17. Orcesi S, 2008, EUR J PAEDIATR NEURO, V12, P408, DOI 10.1016/j.ejpn.2007.10.005
  18. Orcesi S, 2009, BRIT MED BULL, V89, P183, DOI 10.1093/bmb/ldn049
  19. Polizzi A, 2001, PEDIATR NEUROL, V24, P300, DOI 10.1016/S0887-8994(00)00268-X
  20. Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373
  21. Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933
  22. Rice GI, 2012, NAT GENET, V44, P1243, DOI 10.1038/ng.2414
  23. Rice GI, 2009, NAT GENET, V41, P829, DOI 10.1038/ng.373
  24. Steenweg ME, 2012, BRAIN, V135, P1387, DOI 10.1093/brain/aws070
  25. Tenembaum S, 2002, NEUROLOGY, V59, P1224, DOI 10.1212/WNL.59.8.1224
  26. Uggetti C, 2009, AM J NEURORADIOL, V30, P1971, DOI 10.3174/ajnr.A1694
  27. Vanderver A, 2015, J CHILD NEUROL, V30, P1343, DOI 10.1177/0883073814562252